Table 1. Patient Demographics at Baseline.
| Variable | Study population (n = 31) |
|---|---|
| Age (years), mean (range) | 48 (26-65) |
| Male, n (%) | 15 (48.4) |
| Race | |
| White, n (%) | 27 (87.1) |
| Black, n (%) | 3 (9.7) |
| Native American, n (%) | 1 (3.2) |
| Ethnicity | |
| Hispanic | 11 (35.5) |
| Not Hispanic | 20 (64.5) |
| Diabetes type | |
| Type 1 | 10 (32.3) |
| Type 2 | 21 (67.7) |
| Albumin ≥3.5 g/dL, n (%) | 29 (93.5) |
| Glycemic indices | |
| A1C (%), mean ± SD | 9.5 ± 1.5 |
| FPG (mg/dL), mean ± SD | 189.2 ± 68.53 |
| MBGa (mg/dL), mean ± SD | 203.7 ± 62.13 |
| Fructosamine, (mmol/L), mean ± SD | 347.5 ± 55.06 |
| GA (%), mean ± SD | 23.39 ± 4.42 |
| Weight (kg), mean ± SD | 90.2 ± 22.68 |
| BMI (kg/m2), mean ± SD | 31.0 ± 6.31 |
Abbreviations: A1C = hemoglobin A1C; BMI = body mass index; FPG = fasting plasma glucose; GA = glycated albumin; MBG = mean blood glucose.
a
Estimated based on the average area under the curve (AUC) for data obtained through multiple readings taken on the day before (or after) each scheduled study visit (Method 1).